Genomic Differences in Thyroid Cancers From Primary Sites Versus Distant Metastases in Individual Patients: A Clinical Perspective and Preliminary Report

ABSTRACT Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unc...

Full description

Saved in:
Bibliographic Details
Published inHead & neck Vol. 47; no. 7; pp. 1907 - 1927
Main Authors Lin, Yen‐Bo, Hu, Hsiang‐Wei, Chung, An‐Ko, Lu, Jin‐Ying, Wu, Wan‐Chen, Chiu, I‐Hsuan, Chu, I, Lin, Chia‐Chi, Lee, Jih‐Hsiang, Nien, Feng‐Jung, Chen, Kuen‐Yuan, Wu, Ming‐Hsun, Chen, Chun‐Nan, Wang, Chun‐Wei, Kuo, Ting‐Chun, Lin, Chia‐Hung, Cheng, Mei‐Fang, Chiu, Wei‐Yih, Kuo, Shuenn‐Wen, Hsih, Wen‐Hui, Wang, Chih‐Yuan, Yang, Wei‐Shiung, Chen, Pei‐Lung, Shih, Shyang‐Rong
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.07.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear. Methods Patients with TC and distant metastasis were recruited for genetic analysis. Results Using a TC‐specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2–SHTN1 and RFTN1–BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032). Conclusion Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.
AbstractList ABSTRACT Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear. Methods Patients with TC and distant metastasis were recruited for genetic analysis. Results Using a TC‐specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2–SHTN1 and RFTN1–BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032). Conclusion Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.
Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling‐risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear. Methods Patients with TC and distant metastasis were recruited for genetic analysis. Results Using a TC‐specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2–SHTN1 and RFTN1–BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032). Conclusion Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.
Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear. Patients with TC and distant metastasis were recruited for genetic analysis. Using a TC-specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2-SHTN1 and RFTN1-BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032). Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.
Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear.BACKGROUNDDistant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and sampling-risk concerns. Differences between samples from thyroid and distant metastasis within individual patients are unclear.Patients with TC and distant metastasis were recruited for genetic analysis.METHODSPatients with TC and distant metastasis were recruited for genetic analysis.Using a TC-specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2-SHTN1 and RFTN1-BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032).RESULTSUsing a TC-specific NGS panel, 66 specimens from 29 patients were analyzed, identifying 16 mutations and 4 fusions, including two novel fusions (FGFR2-SHTN1 and RFTN1-BRAF). Genetic alterations differed between primary and metastatic sites in nine patients (31%), predominantly in additional oncogenic alterations (89%). More genetic alterations were found at the primary site in three patients and metastatic sites in four. Distinct mutations were found in two patients. A longer time interval between specimen acquisitions was significantly associated with genetic discrepancies (p = 0.032).Patterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.CONCLUSIONPatterns of genetic discrepancies between primary and metastatic TC vary, offering valuable insights for clinical practice.
Author Lin, Yen‐Bo
Lu, Jin‐Ying
Chu, I
Chen, Kuen‐Yuan
Yang, Wei‐Shiung
Hsih, Wen‐Hui
Chen, Chun‐Nan
Chen, Pei‐Lung
Wu, Ming‐Hsun
Lin, Chia‐Hung
Chung, An‐Ko
Kuo, Shuenn‐Wen
Lee, Jih‐Hsiang
Wang, Chun‐Wei
Nien, Feng‐Jung
Cheng, Mei‐Fang
Chiu, Wei‐Yih
Lin, Chia‐Chi
Kuo, Ting‐Chun
Wu, Wan‐Chen
Chiu, I‐Hsuan
Hu, Hsiang‐Wei
Wang, Chih‐Yuan
Shih, Shyang‐Rong
Author_xml – sequence: 1
  givenname: Yen‐Bo
  surname: Lin
  fullname: Lin, Yen‐Bo
  organization: National Taiwan University Hospital, Bei‐Hu Branch
– sequence: 2
  givenname: Hsiang‐Wei
  surname: Hu
  fullname: Hu, Hsiang‐Wei
  organization: National Taiwan University Hospital
– sequence: 3
  givenname: An‐Ko
  surname: Chung
  fullname: Chung, An‐Ko
  organization: Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine
– sequence: 4
  givenname: Jin‐Ying
  surname: Lu
  fullname: Lu, Jin‐Ying
  organization: National Taiwan University Hospital
– sequence: 5
  givenname: Wan‐Chen
  surname: Wu
  fullname: Wu, Wan‐Chen
  organization: National Taiwan University Hospital
– sequence: 6
  givenname: I‐Hsuan
  surname: Chiu
  fullname: Chiu, I‐Hsuan
  organization: National Taiwan University Hospital
– sequence: 7
  givenname: I
  surname: Chu
  fullname: Chu, I
  organization: National Taiwan University College of Medicine
– sequence: 8
  givenname: Chia‐Chi
  surname: Lin
  fullname: Lin, Chia‐Chi
  organization: National Taiwan University Hospital
– sequence: 9
  givenname: Jih‐Hsiang
  surname: Lee
  fullname: Lee, Jih‐Hsiang
  organization: National Taiwan University Hospital, Hsin‐Chu Branch
– sequence: 10
  givenname: Feng‐Jung
  surname: Nien
  fullname: Nien, Feng‐Jung
  organization: National Taiwan University Cancer Center
– sequence: 11
  givenname: Kuen‐Yuan
  surname: Chen
  fullname: Chen, Kuen‐Yuan
  organization: National Taiwan University Hospital
– sequence: 12
  givenname: Ming‐Hsun
  surname: Wu
  fullname: Wu, Ming‐Hsun
  organization: National Taiwan University Hospital
– sequence: 13
  givenname: Chun‐Nan
  surname: Chen
  fullname: Chen, Chun‐Nan
  organization: National Taiwan University Hospital
– sequence: 14
  givenname: Chun‐Wei
  surname: Wang
  fullname: Wang, Chun‐Wei
  organization: National Taiwan University Hospital
– sequence: 15
  givenname: Ting‐Chun
  surname: Kuo
  fullname: Kuo, Ting‐Chun
  organization: National Taiwan University Hospital
– sequence: 16
  givenname: Chia‐Hung
  surname: Lin
  fullname: Lin, Chia‐Hung
  organization: National Taiwan University Hospital
– sequence: 17
  givenname: Mei‐Fang
  surname: Cheng
  fullname: Cheng, Mei‐Fang
  organization: National Taiwan University Hospital
– sequence: 18
  givenname: Wei‐Yih
  orcidid: 0000-0003-3124-7121
  surname: Chiu
  fullname: Chiu, Wei‐Yih
  organization: National Taiwan University Hospital
– sequence: 19
  givenname: Shuenn‐Wen
  surname: Kuo
  fullname: Kuo, Shuenn‐Wen
  organization: National Taiwan University College of Medicine
– sequence: 20
  givenname: Wen‐Hui
  surname: Hsih
  fullname: Hsih, Wen‐Hui
  organization: National Taiwan University Hospital, Yun‐Lin Branch
– sequence: 21
  givenname: Chih‐Yuan
  orcidid: 0000-0002-6742-3935
  surname: Wang
  fullname: Wang, Chih‐Yuan
  organization: National Taiwan University College of Medicine
– sequence: 22
  givenname: Wei‐Shiung
  surname: Yang
  fullname: Yang, Wei‐Shiung
  organization: Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine
– sequence: 23
  givenname: Pei‐Lung
  surname: Chen
  fullname: Chen, Pei‐Lung
  organization: National Taiwan University Hospital
– sequence: 24
  givenname: Shyang‐Rong
  orcidid: 0000-0001-7424-1358
  surname: Shih
  fullname: Shih, Shyang‐Rong
  email: srshih@ntu.edu.tw
  organization: National Taiwan University College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39936351$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1rFTEYhYNU7Icu_AMScKOLafM5M3FXbj-hYtHqdshN3tCUmeSaZCr3p_hvzXWqC8FVDofnHMJ7DtFeiAEQek3JMSWEndyDPWZ9lc_QASWqawgX3d5OC95w0ol9dJjzAyGEt4K9QPtcKd5ySQ_Qz0sIcfIGn3nnIEEwkLEP-O5-m6K3eKWrkzK-SHHCt8lPOm3xF18q9a36c67BXHQo-CMUXVVe8tfB-kdvZz3iW108hJI_4FO8Gn3wZmfW8AZM8Y-AdbC1GkY_-bCr_wybmMpL9NzpMcOrp_cIfb04v1tdNTefLq9XpzeN4ZSTRkpHDbUUVEeMYVYwQWwLbaetVtyxXos1s50mayZVa5hTznRCWel64qhr-RF6t_RuUvw-Qy7D5LOBcdQB4pwHTlvZS8lEX9G3_6APcU6h_m7gjClCpVJdpd48UfN6AjtslqsNf45egfcLYFLMOYH7i1Ay7AYd6qDD70Ere7KwP_wI2_-Dw9X52ZL4BbMhoh0
Cites_doi 10.1186/s12943-018-0786-0
10.1002/lary.28722
10.1089/thy.2015.0020
10.1530/ERC-19-0452
10.1016/j.jtho.2018.09.014
10.1186/s13059-019-1842-9
10.1016/j.bbcan.2017.01.003
10.1158/0008-5472.CAN-09-0727
10.1093/nar/gkq603
10.1186/s12885-021-07888-4
10.1093/bioinformatics/btp324
10.1371/journal.pone.0115383
10.1210/jc.2016-2785
10.3389/fendo.2021.623182
10.1038/s41574-023-00920-6
10.1038/s41588-020-0633-2
10.1089/thy.2019.0052
10.1089/thy.2015.0527
10.1016/j.ygeno.2020.06.020
ContentType Journal Article
Copyright 2025 Wiley Periodicals LLC.
Copyright_xml – notice: 2025 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
DOI 10.1002/hed.28100
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1097-0347
EndPage 1927
ExternalDocumentID 39936351
10_1002_hed_28100
HED28100
Genre researchArticle
Journal Article
GrantInformation_xml – fundername: Wong‐Yuan Endocrine Fund, Taiwan
– fundername: National Taiwan University Hospital
– fundername: the Liver Disease Prevention and Treatment Research Foundation, Taiwan
– fundername: National Science and Technology Council (Taiwan)
  funderid: 111‐2314‐B‐002‐194‐MY3
– fundername: National Taiwan University
– fundername: Wong-Yuan Endocrine Fund, Taiwan
– fundername: National Science and Technology Council (Taiwan)
  grantid: 111-2314-B-002-194-MY3
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AEQDE
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
ID FETCH-LOGICAL-c3130-55f1c1d1e970cc2d4240d6e67ada93f28a4b2d7a0b2596c2f9fc749d5f80f1f63
IEDL.DBID DR2
ISSN 1043-3074
1097-0347
IngestDate Fri Jul 11 01:43:35 EDT 2025
Wed Jul 23 07:40:39 EDT 2025
Tue Jun 10 01:31:05 EDT 2025
Thu Jul 31 00:23:31 EDT 2025
Mon Jun 09 09:20:18 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords fusion genes
thyroid cancer
mutations
oncogene
metastasis
Language English
License 2025 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3130-55f1c1d1e970cc2d4240d6e67ada93f28a4b2d7a0b2596c2f9fc749d5f80f1f63
Notes The first three authors are co‐first authors.
Funding
This work was supported by Wong‐Yuan Endocrine Fund, Taiwan; the Liver Disease Prevention and Treatment Research Foundation, Taiwan; National Taiwan University; National Taiwan University Hospital; National Science and Technology Council (Taiwan).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-3124-7121
0000-0002-6742-3935
0000-0001-7424-1358
PMID 39936351
PQID 3229015997
PQPubID 996355
PageCount 21
ParticipantIDs proquest_miscellaneous_3165855248
proquest_journals_3229015997
pubmed_primary_39936351
crossref_primary_10_1002_hed_28100
wiley_primary_10_1002_hed_28100_HED28100
PublicationCentury 2000
PublicationDate July 2025
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: July 2025
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Houston
PublicationTitle Head & neck
PublicationTitleAlternate Head Neck
PublicationYear 2025
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2009; 69
2009; 25
2018; 17
2010; 38
2021; 21
2021; 12
2017; 2017
2019; 20
2020; 52
2020; 30
2019; 14
2020; 27
2024; 20
2021; 131
2017; 1867
2020; 112
2014; 9
2017; 102
2016; 26
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
Chakravarty D. (e_1_2_8_14_1) 2017; 2017
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_21_1
e_1_2_8_11_1
e_1_2_8_12_1
References_xml – volume: 20
  start-page: 93
  issue: 2
  year: 2024
  end-page: 110
  article-title: Genomic Alterations in Thyroid Cancer: Biological and Clinical Insights
  publication-title: Nature Reviews Endocrinology
– volume: 52
  start-page: 692
  issue: 7
  year: 2020
  end-page: 700
  article-title: Lymph Node Metastases Develop Through a Wider Evolutionary Bottleneck Than Distant Metastases
  publication-title: Nature Genetics
– volume: 69
  start-page: 4885
  issue: 11
  year: 2009
  end-page: 4893
  article-title: Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine‐Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for , , and
  publication-title: Cancer Research
– volume: 26
  start-page: 1
  issue: 1
  year: 2016
  end-page: 133
  article-title: 2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
  publication-title: Thyroid
– volume: 102
  start-page: 1898
  issue: 6
  year: 2017
  end-page: 1907
  article-title: TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
  publication-title: Journal of Clinical Endocrinology and Metabolism
– volume: 21
  issue: 1
  year: 2021
  article-title: Multi‐Omics Analysis of Genomics, Epigenomics and Transcriptomics for Molecular Subtypes and Core Genes for Lung Adenocarcinoma
  publication-title: BMC Cancer
– volume: 25
  start-page: 1754
  issue: 14
  year: 2009
  end-page: 1760
  article-title: Fast and Accurate Short Read Alignment With Burrows–Wheeler Transform
  publication-title: Bioinformatics
– volume: 20
  issue: 1
  year: 2019
  article-title: Accuracy Assessment of Fusion Transcript Detection via Read‐Mapping and De Novo Fusion Transcript Assembly‐Based Methods
  publication-title: Genome Biology
– volume: 1867
  start-page: 151
  issue: 2
  year: 2017
  end-page: 161
  article-title: Tumor Evolution: Linear, Branching, Neutral or Punctuated?
  publication-title: Biochimica et Biophysica Acta, Reviews on Cancer
– volume: 26
  start-page: 672
  issue: 5
  year: 2016
  end-page: 682
  article-title: Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer
  publication-title: Thyroid
– volume: 30
  start-page: 42
  issue: 1
  year: 2020
  end-page: 56
  article-title: Whole‐Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
  publication-title: Thyroid
– volume: 27
  start-page: 285
  issue: 5
  year: 2020
  end-page: 293
  article-title: Genetic Profile of Advanced Thyroid Cancers in Relation to Distant Metastasis
  publication-title: Endocrine‐Related Cancer
– volume: 2017
  year: 2017
  article-title: OncoKB: A Precision Oncology Knowledge Base
  publication-title: Journal of Clinical Oncology: Precision Oncology
– volume: 112
  start-page: 3306
  issue: 5
  year: 2020
  end-page: 3314
  article-title: lncRNA‐RP11‐156p1.3, Novel Diagnostic and Therapeutic Targeting via CRISPR/Cas9 Editing in Hepatocellular Carcinoma
  publication-title: Genomics
– volume: 17
  issue: 1
  year: 2018
  article-title: Novel Targeted Therapies and Immunotherapy for Advanced Thyroid Cancers
  publication-title: Molecular Cancer
– volume: 12
  year: 2021
  article-title: Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
  publication-title: Frontiers in Endocrinology
– volume: 131
  start-page: 237
  issue: 1
  year: 2021
  end-page: 244
  article-title: Prevalence and Risk of Metastatic Thyroid Cancers and Management Outcomes: A National Perspective
  publication-title: Laryngoscope
– volume: 38
  issue: 16
  year: 2010
  article-title: ANNOVAR: Functional Annotation of Genetic Variants From High‐Throughput Sequencing Data
  publication-title: Nucleic Acids Research
– volume: 9
  issue: 12
  year: 2014
  article-title: Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
  publication-title: PLoS One
– volume: 14
  start-page: 54
  issue: 1
  year: 2019
  end-page: 62
  article-title: Detection of Known and Novel FGFR Fusions in Non‐Small Cell Lung Cancer by Comprehensive Genomic Profiling
  publication-title: Journal of Thoracic Oncology
– ident: e_1_2_8_4_1
  doi: 10.1186/s12943-018-0786-0
– ident: e_1_2_8_2_1
  doi: 10.1002/lary.28722
– ident: e_1_2_8_3_1
  doi: 10.1089/thy.2015.0020
– ident: e_1_2_8_11_1
  doi: 10.1530/ERC-19-0452
– ident: e_1_2_8_19_1
  doi: 10.1016/j.jtho.2018.09.014
– ident: e_1_2_8_15_1
  doi: 10.1186/s13059-019-1842-9
– volume: 2017
  year: 2017
  ident: e_1_2_8_14_1
  article-title: OncoKB: A Precision Oncology Knowledge Base
  publication-title: Journal of Clinical Oncology: Precision Oncology
– ident: e_1_2_8_17_1
  doi: 10.1016/j.bbcan.2017.01.003
– ident: e_1_2_8_10_1
  doi: 10.1158/0008-5472.CAN-09-0727
– ident: e_1_2_8_13_1
  doi: 10.1093/nar/gkq603
– ident: e_1_2_8_21_1
  doi: 10.1186/s12885-021-07888-4
– ident: e_1_2_8_12_1
  doi: 10.1093/bioinformatics/btp324
– ident: e_1_2_8_18_1
  doi: 10.1371/journal.pone.0115383
– ident: e_1_2_8_9_1
  doi: 10.1210/jc.2016-2785
– ident: e_1_2_8_7_1
  doi: 10.3389/fendo.2021.623182
– ident: e_1_2_8_16_1
  doi: 10.1038/s41574-023-00920-6
– ident: e_1_2_8_6_1
  doi: 10.1038/s41588-020-0633-2
– ident: e_1_2_8_8_1
  doi: 10.1089/thy.2019.0052
– ident: e_1_2_8_5_1
  doi: 10.1089/thy.2015.0527
– ident: e_1_2_8_20_1
  doi: 10.1016/j.ygeno.2020.06.020
SSID ssj0003642
Score 2.4515634
Snippet ABSTRACT Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per...
Distant metastasis is a leading cause of thyroid cancer (TC)-related deaths. Genetic profiling is typically limited to one sample per patient due to cost and...
Background Distant metastasis is a leading cause of thyroid cancer (TC)‐related deaths. Genetic profiling is typically limited to one sample per patient due to...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 1907
SubjectTerms Adult
Aged
Female
Fibroblast growth factor receptor 2
fusion genes
Genetic analysis
High-Throughput Nucleotide Sequencing
Humans
Male
Metastases
Metastasis
Middle Aged
Mutation
mutations
Neoplasm Metastasis - genetics
oncogene
Thyroid cancer
Thyroid gland
Thyroid Neoplasms - genetics
Thyroid Neoplasms - pathology
Title Genomic Differences in Thyroid Cancers From Primary Sites Versus Distant Metastases in Individual Patients: A Clinical Perspective and Preliminary Report
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.28100
https://www.ncbi.nlm.nih.gov/pubmed/39936351
https://www.proquest.com/docview/3229015997
https://www.proquest.com/docview/3165855248
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPfXCQ-URKJVBHLhkGzuOk9BT1XZZkIoqaKUekCI_1Qo1izbZA_wT_i1jO8mqICTEzUns-DUz_vyYzwCvK5XRShdVyi3PUy60SbGbZUqFRJOZCyWCh9zZR7G45B-uiqstOBx9YSI_xLTg5jUj2Guv4FJ1BxvS0GtrZqzCB7S__qyWB0SfNtRRueBxpxOLgHLMR1ahjB1MKe-ORX8AzLt4NQw48_vwZSxqPGfydbbu1Uz_-I3F8T_r8gDuDUCUHEXJeQhbtt2Fn-9scFMmJ8O9KWhFyE1LLq6_r5Y3hhx7GVl1ZL5a3pLzSFRBPiNq7YhfeFt3mNDDzZ6c2V5iqIvp309uX-Q8Erl2b8kRGUhJ8eXG5ZPI1uCvsUK3wVWYxCnCI7icn14cL9Lh8oZU5zgupkXhqKaG2rrMtGaGI3QwwopSGlnnjlWSK2ZKmSmcgAnNXO10yWtTuCpz1In8MWy3y9Y-BWKsUZLrslaejJAaaV1ZIpBVtHCefzCBV2M3Nt9i1ZvIxswabNkmtGwCe2MHN4Oadk3u2e4R0NVlAi-nz6hgftdEtna5xjgUQVpRMF4l8CQKxpSLR3eI2GgCb0L3_j37ZnF6EgLP_j3qc9hh_rbhcDh4D7b71dq-QAjUq_0g678A4JsCTw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcoALD_FoSikGceCSbZw4TlL1UrVdttCtKthKvaDIr6gVarbaZA_wT_i3jO0kqxYhIW5OYsePmbE_P-YzwPtcRjRXaR4yw5KQcaVDFLMIKRfYZSZccuchNz3lk3P26SK9WIO93hfG80MMC27WMlx_bQ3cLkjvrFhDL40exTk-3IP79kZvN6H6siKPSjjze51YCNRk1vMKRfHOkPT2aPQHxLyNWN2QM34M3_rC-pMm30fLVo7Uzzs8jv9bmyfwqMOiZN8rz1NYM_Uz-PXROE9lcthdnYIdCbmqyezyx2J-pcmBVZNFQ8aL-TU581wV5CsC14bYtbdlgwkt4mzJ1LQCQ41Pfzx4fpEzz-Xa7JJ90vGS4suV1ycRtcZfY42unbcw8bOE53A-PpodTMLu_oZQJTg0hmlaUUU1NUUWKRVrhuhBc8MzoUWRVHEumIx1JiKJczCu4qqoVMYKnVZ5VNGKJy9gvZ7XZgOINloKprJCWj5CqoWpsgyxrKRpZSkIA3jXy7G88VUvPSFzXGLLlq5lA9jqJVx2ltqUiSW8R0xXZAG8HT6jjdmNE1Gb-RLjUMRpaRqzPICXXjOGXCzAQ9BGA_jg5Pv37MvJ0aELbP571DfwYDKbnpQnx6efX8HD2F4-7M4Kb8F6u1ia14iIWrntFP839PEGag
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFH4qRUJcWMTSdAGDOHDJNE4cJ2lPVafDFGg1glbqASlyvKgVaqaaZA7wT_i3fbaTjApCQtycxI6X9579eXmfAd7lVURzmeYh0ywJGZcqRDGLkHKBXWbCK-485E5O-fScfbxIL9Zgv_eF8fwQw4KbtQzXX1sDv1Fmd0UaeqnVKM7x4R7cZzzKrUqPv6y4oxLO_FYnlgEVmfW0QlG8OyS9Oxj9gTDvAlY34kwew7e-rP6gyffRsq1G8udvNI7_WZkn8KhDouTAq85TWNP1M_j1QTs_ZTLuLk7BboRc1eTs8sdifqXIoVWSRUMmi_k1mXmmCvIVYWtD7MrbssGEFm-25ES3AkONT388-H2RmWdybfbIAelYSfHlyueTiFrhr7FC185XmPg5wnM4nxydHU7D7vaGUCY4MIZpaqikiuoii6SMFUPsoLjmmVCiSEycC1bFKhNRhTMwLmNTGJmxQqUmjww1PHkB6_W81htAlFaVYDIrKstGSJXQJssQyVY0NZaAMIC3vRjLG1_10tMxxyW2bOlaNoDtXsBlZ6dNmVi6e0R0RRbAm-EzWpjdNhG1ni8xDkWUlqYxywN46RVjyMXCO4RsNID3Trx_z76cHo1dYPPfo76GB7PxpPx8fPppCx7G9uZhd1B4G9bbxVLvIBxqq1dO7W8B_-QFIg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genomic+Differences+in+Thyroid+Cancers+From+Primary+Sites+Versus+Distant+Metastases+in+Individual+Patients%3A+A+Clinical+Perspective+and+Preliminary+Report&rft.jtitle=Head+%26+neck&rft.au=Lin%2C+Yen%E2%80%90Bo&rft.au=Hu%2C+Hsiang%E2%80%90Wei&rft.au=Chung%2C+An%E2%80%90Ko&rft.au=Lu%2C+Jin%E2%80%90Ying&rft.date=2025-07-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1043-3074&rft.eissn=1097-0347&rft.volume=47&rft.issue=7&rft.spage=1907&rft.epage=1927&rft_id=info:doi/10.1002%2Fhed.28100&rft.externalDBID=10.1002%252Fhed.28100&rft.externalDocID=HED28100
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon